Jean-Pascal Machiels

Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial

Johann S. de Bono, Stéphane Oudard, Mustafa Özgüroğlu et al. · The Lancet · 2010 · 3.3K citations

Urology, Medicine, Pharmacology +7

Cyclophosphamide, doxorubicin, and paclitaxel enhance the antitumor immune response of granulocyte/macrophage-colony stimulating factor-secreting whole-cell vaccines in HER-2/neu tolerized mice.

Jean-Pascal Machiels, R. Todd Reilly, Leisha A. Emens et al. · PubMed · 2001 · 459 citations

Immunology, Immunoediting, Immunologic Mechanism +19

Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial

R. Wendel Naumann, Antoine Hollebecque, Tim Meyer et al. · Journal of Clinical Oncology · 2019 · 423 citations

Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer

Kenneth J. Pienta, Jean-Pascal Machiels, Dirk Schrijvers et al. · Investigational New Drugs · 2012 · 389 citations

Cnto 888, Medicine, Human Monoclonal Antibody +8

Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus

Giuseppe Curigliano, Susana Banerjee, Andrés Cervantes et al. · Annals of Oncology · 2020 · 303 citations · Full text

Health Policy, Medicine, Global Health +9